CDKN1C expression in Beckwith-Wiedemann syndrome patients with allele imbalance
暂无分享,去创建一个
[1] T. Ludwig,et al. Mouse mutant embryos overexpressing IGF-II exhibit phenotypic features of the Beckwith-Wiedemann and Simpson-Golabi-Behmel syndromes. , 1997, Genes & development.
[2] W. Reik,et al. Transactivation of Igf2 in a mouse model of Beckwith–Wiedemann syndrome , 1997, Nature.
[3] Y. Fukushima,et al. New p57KIP2 mutations in Beckwith-Wiedemann syndrome , 1997, Human Genetics.
[4] A. Feinberg,et al. Low frequency of p57KIP2 mutation in Beckwith-Wiedemann syndrome. , 1997, American journal of human genetics.
[5] B. Tycko,et al. Coding mutations in p57KIP2 are present in some cases of Beckwith-Wiedemann syndrome but are rare or absent in Wilms tumors. , 1997, American journal of human genetics.
[6] S. Elledge,et al. Altered cell differentiation and proliferation in mice lacking p57KIP2 indicates a role in Beckwith–Wiedemann syndrome , 1997, Nature.
[7] W. Reik,et al. Epigenetic modification and uniparental inheritance of H19 in Beckwith-Wiedemann syndrome. , 1997, Journal of medical genetics.
[8] E. Algar,et al. Mutation analysis of the WT1 gene in sporadic childhood leukaemia , 1997, Leukemia.
[9] J. Clayton-Smith,et al. Imprinting mutation in the Beckwith-Wiedemann syndrome leads to biallelic IGF2 expression through an H19-independent pathway. , 1996, Human molecular genetics.
[10] A. Reeve,et al. Role of genomic imprinting in Wilms' tumour and overgrowth disorders. , 1996, Medical and pediatric oncology.
[11] Y. Fukushima,et al. An imprinted gene p57KIP2 is mutated in Beckwith–Wiedemann syndrome , 1996, Nature Genetics.
[12] A. Feinberg,et al. Imprinting of the gene encoding a human cyclin-dependent kinase inhibitor, p57KIP2, on chromosome 11p15. , 1996, Proceedings of the National Academy of Sciences of the United States of America.
[13] W. Reik,et al. Imprinting mutations in the Beckwith-Wiedemann syndrome suggested by altered imprinting pattern in the IGF2-H19 domain. , 1995, Human molecular genetics.
[14] L. Simms,et al. Homozygous intragenic deletion in the WT1 gene in a sporadic Wilms' tumour associated with high levels of expression of a truncated transcript , 1995, Human mutation.
[15] E. Maher,et al. Beckwith-Wiedermann syndrome , 1994 .
[16] J. A. Glatz,et al. The insulin-like growth factor 1 receptor gene is normally biallelically expressed in human juvenile tissue and tumours. , 1993, Human molecular genetics.
[17] R. Weksberg,et al. Disruption of insulin–like growth factor 2 imprinting in Beckwith–Wiedemann syndrome , 1993, Nature genetics.
[18] G. Evans,et al. Highly polymorphic tetramer repeat (GATA)n on human chromosome 11p15.3. , 1993, Genomics.
[19] D. Viljoen,et al. Evidence for paternal imprinting in familial Beckwith-Wiedemann syndrome. , 1992, Journal of medical genetics.
[20] M. Introna,et al. A simple and rapid method to analyze specific mRNAs from few cells in a semi-quantitative way using the polymerase chain reaction. , 1991, PCR methods and applications.
[21] D. S. Rath,et al. Tetranucleotide repeat polymorphism at the human tyrosine hydroxylase gene (TH). , 1991, Nucleic acids research.
[22] N. Hastie,et al. Dads and disomy and disease , 1991, Nature.
[23] Nan Faion T. Wu,et al. The Beckwith-Wiedemann Syndrome , 1974, Clinical pediatrics.